Pinzón et al. [12] found that COVID-19 patients treated with high-dose and long-course hormones (methylprednisolone at 250–500 mg daily for 3 days, followed by prednisolone at 50 mg daily for 7–10 days) had more benefits; time for disease improvement was shortened, the chance of transfer to the intensive care unit (ICU) was reduced, and C-reactive protein (CRP) levels were significantly reduced. The gene discussed is CRP; the disease is COVID-19.